Stocks and Investing Stocks and Investing
Wed, July 20, 2022

Richard Newitter Maintained (BSX) at Strong Buy with Decreased Target to $45 on, Jul 20th, 2022


Published on 2024-10-27 22:04:52 - WOPRAI, Richard Newitter
  Print publication without navigation


Richard Newitter of Truist Securities, Maintained "Boston Scientific Corporation" (BSX) at Strong Buy with Decreased Target from $51 to $45 on, Jul 20th, 2022.

Richard has made no other calls on BSX in the last 4 months.



There are 8 other peers that have a rating on BSX. Out of the 8 peers that are also analyzing BSX, 1 agrees with Richard's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $48 on, Thursday, April 28th, 2022


These are the ratings of the 7 analyists that currently disagree with Richard


  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $46 on, Friday, July 15th, 2022
  • Mike Polark of "Wolfe Research" Initiated at Buy on, Wednesday, July 6th, 2022
  • William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $43 on, Wednesday, June 29th, 2022
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $45 on, Friday, June 24th, 2022
  • Mike Matson of "Needham" Upgraded from Hold to Strong Buy and Held Target at $48 on, Friday, May 27th, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 17th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $50 on, Thursday, April 28th, 2022
Contributing Sources